Wednesday, December 30, 2009 1:21:59 PM
44.) Imaging 3 (IMGG.OB) ($0.64) is currently awaiting a decision by the FDA for marketing clearance of their DViS (Dominion Volumetric Imaging Scanner), which is a patented breakthrough mobile fluoroscopy technology that produces high-quality 3D images in real time by utilizing photo-fluoroscopy. On a 9/24/09 conference call, CEO Dean Janes announced that the next submission to the FDA will take place on 9/30/09. The CEO has stated that a response from the Agency could come within 15-30 days post-submission (as early as the end of September), but that all of his timelines were only estimates and not formal FDA deadlines and subject to change and/or delays. The CEO provided guidance that the Company may be 1-2 filings away from FDA marketing clearance based on his estimation and further replies may be necessary to respond to the Agency for a final decision by year-end as the ultimate goal so that 12/31/09 is the estimated date for this entry.
FEATURED North Bay Resources Announces Federal (MSHA) Approval of Mt. Vernon Gold Mine Operational Plan and Commencement of Production, Sierra County, California • Oct 21, 2024 9:00 AM
Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development • HYDI • Oct 21, 2024 9:00 AM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM